The global Longum market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.

Bifidobacterium longum is a species of small pathogenic bacteria, which naturally occurs in gastrointestinal tracts of human and other animals. The bacterium is added to different types of foods, beverages, and dietary supplements as a probiotic, as it provides many health benefits such as improved digestion and bowel movements.

The growth of the global longum market is driven by increase in demand for probiotic dietary supplements with probiotic ingredients and surge in awareness towards healthy food products. Furthermore, rise in disposable income allows consumers to purchase healthy alternatives to regular food products, which is expected to fuel the growth of the market. However, low level of awareness and meagre purchasing power in underdeveloped countries are anticipated to hinder the market growth.

United States market for Longum is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Longum is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Longum is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Longum players cover ATCC Inc, BioGaia AB, Mystic Pharmaceuticals Inc, Hanson Ltd, Biofodan A/S, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

Infinity Market Research newest research report, the Longum Industry Forecast looks at past sales and reviews total world Longum sales in 2024, providing a comprehensive analysis by region and market sector of projected Longum sales for 2025 through 2031. With Longum sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Longum industry.

This Insight Report provides a comprehensive analysis of the global Longum landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Longum portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Longum market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Longum and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Longum.

This report presents a comprehensive overview, market shares, and growth opportunities of Longum market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:

    0.2g/Piece
    0.25g/Piece

Segmentation by Application:

    Medicine
    Others

This report also splits the market by region:

    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration.

    ATCC Inc
    BioGaia AB
    Mystic Pharmaceuticals Inc
    Hanson Ltd
    Biofodan A/S
    BioCare Copenhagen ApS
    Danisco A/S
    Danone SA
    Deerland Enzymes Inc

Key Questions Addressed in this Report

What is the 10-year outlook for the global Longum market?
What factors are driving Longum market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Longum market opportunities vary by end market size?
How does Longum break out by Type, by Application?